Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03164096
Other study ID # obstanesth
Secondary ID
Status Recruiting
Phase Phase 4
First received May 20, 2017
Last updated March 28, 2018
Start date June 1, 2017
Est. completion date December 10, 2018

Study information

Verified date January 2018
Source Assiut University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Although the exact mechanism remains unknown, the association of pregnancy and decreased local anesthetic requirement is clear. demonstrated that more local anesthetic is required for cesarean section under combined spinal-epidural anesthesia in preterm compared with term patients.


Description:

However, in pregnant patients, venous engorgement is prominent in the supine but not the lateral position, which suggests direct compression of the inferior vena cava by the gravid uterus. Second, an increase in intraabdominal pressure may affect the retroperitoneal area and may cause inward movement of soft tissue in the intervertebral foramina. Recent magnetic resonance imaging studies in pregnant patients, although without intraabdominal pressure measurements, suggested the latter because they showed limited contact of engorged veins along the dural sac which may therefore not be responsible for compression of the dura.

If elevated intraabdominal pressure contributes to high anesthetic spread during pregnancy, one would expect a relationship between intraabdominal pressure and maximum sensory block level.


Recruitment information / eligibility

Status Recruiting
Enrollment 100
Est. completion date December 10, 2018
Est. primary completion date December 1, 2018
Accepts healthy volunteers No
Gender Female
Age group 18 Years to 40 Years
Eligibility Inclusion Criteria:

- adult female partner

- aged 18 to 40 years.

- scheduled for elective cesarean section.

Exclusion Criteria:

- Patients with coagulopathy or under anti-coagulation therapy.

- Gastrointestinal disease,

- motion sickness.

- diabetes mellitus.

- Patients with preeclampsia,

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Bupivacaine Hydrochloride
intrathecal bupivacaine will be used for spinal anesthesia in obstetric patients undergoing C-section

Locations

Country Name City State
Egypt Assiut governorate Assiut

Sponsors (1)

Lead Sponsor Collaborator
Assiut University

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary sensory level effect of different parameters in sensory level from allocation until 24 hours post-operative
Primary motor block effect of different parameters in motor level from allocation until 24 hours post-operative
Secondary hypotension incidence of hypotension after spinal anesthesia from allocation until 24 hours post-operative
Secondary vasopressor consumption total dose of ephedrine consumed by the patients from allocation until 24 hours post-operative
See also
  Status Clinical Trial Phase
Completed NCT03133091 - Epidural Analgesia During Labour Phase 3
Completed NCT05099055 - Dexmedetomine as Adjuvant for Spinal Anesthesia in Elective Cesarian Sections : a Pilot Study Phase 3
Completed NCT02958215 - Phenylephrine and Hypotension During Spinal Anesthesia for Cesarean Section Phase 2
Active, not recruiting NCT03167905 - CODEPAD (Collaborative Outcomes of DEpression and Pain Associated With Delivery) Phase 2/Phase 3
Completed NCT05091294 - The Effect of Injection Rate of Local Anesthetic in Caesarean Section N/A
Completed NCT04205344 - Subarachnoid Bupivacaine in Obese Patients Undergoing Cesarean Delivery Phase 4
Completed NCT03333902 - The Comparison Of Nerve Blocks In Cesarean Delivery N/A